195 related articles for article (PubMed ID: 12957325)
21. What are the effects of peroxisome proliferator-activated receptor agonists on adiponectin, tumor necrosis factor-alpha, and other cytokines in insulin resistance?
Boyle PJ
Clin Cardiol; 2004 Jul; 27(7 Suppl 4):IV11-6. PubMed ID: 15470906
[TBL] [Abstract][Full Text] [Related]
22. [Role of the peroxisome proliferator-activated receptors (PPARS) in the regulation of lipids and inflammation control].
Bocher V; Chinetti G; Fruchart JC; Staels B
J Soc Biol; 2002; 196(1):47-52. PubMed ID: 12134632
[TBL] [Abstract][Full Text] [Related]
23. PPARS in inflammation, atherosclerosis and thrombosis.
Duez H; Fruchart JC; Staels B
J Cardiovasc Risk; 2001 Aug; 8(4):187-94. PubMed ID: 11550996
[TBL] [Abstract][Full Text] [Related]
24. Role of the peroxisome proliferator-activated receptors (PPAR) in atherosclerosis.
Neve BP; Fruchart JC; Staels B
Biochem Pharmacol; 2000 Oct; 60(8):1245-50. PubMed ID: 11007963
[TBL] [Abstract][Full Text] [Related]
25. Atherosclerosis in type 2 diabetes mellitus and insulin resistance: mechanistic links and therapeutic targets.
Plutzky J; Viberti G; Haffner S
J Diabetes Complications; 2002; 16(6):401-15. PubMed ID: 12477625
[TBL] [Abstract][Full Text] [Related]
26. PPARs and their metabolic modulation: new mechanisms for transcriptional regulation?
Ahmed W; Ziouzenkova O; Brown J; Devchand P; Francis S; Kadakia M; Kanda T; Orasanu G; Sharlach M; Zandbergen F; Plutzky J
J Intern Med; 2007 Aug; 262(2):184-98. PubMed ID: 17645586
[TBL] [Abstract][Full Text] [Related]
27. Clinical interest of PPARs ligands.
Vergès B
Diabetes Metab; 2004 Feb; 30(1):7-12. PubMed ID: 15029092
[TBL] [Abstract][Full Text] [Related]
28. Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists.
Olefsky JM
J Clin Invest; 2000 Aug; 106(4):467-72. PubMed ID: 10953021
[No Abstract] [Full Text] [Related]
29. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.
Marx N; Duez H; Fruchart JC; Staels B
Circ Res; 2004 May; 94(9):1168-78. PubMed ID: 15142970
[TBL] [Abstract][Full Text] [Related]
30. Antiinflammatory properties of PPARgamma agonists following ischemia.
Sundararajan S; Landreth GE
Drug News Perspect; 2004 May; 17(4):229-36. PubMed ID: 15334171
[TBL] [Abstract][Full Text] [Related]
31. Peroxisome proliferator-activated receptor gamma and metabolic disease.
Willson TM; Lambert MH; Kliewer SA
Annu Rev Biochem; 2001; 70():341-67. PubMed ID: 11395411
[TBL] [Abstract][Full Text] [Related]
32. Peroxisome proliferator-activated receptors in macrophage biology: friend or foe?
Moore KJ; Fitzgerald ML; Freeman MW
Curr Opin Lipidol; 2001 Oct; 12(5):519-27. PubMed ID: 11561171
[TBL] [Abstract][Full Text] [Related]
33. Roles of PPARs in health and disease.
Kersten S; Desvergne B; Wahli W
Nature; 2000 May; 405(6785):421-4. PubMed ID: 10839530
[TBL] [Abstract][Full Text] [Related]
34. Peroxisome proliferator-activated receptors and inflammation: from basic science to clinical applications.
Chinetti G; Fruchart JC; Staels B
Int J Obes Relat Metab Disord; 2003 Dec; 27 Suppl 3():S41-5. PubMed ID: 14704743
[TBL] [Abstract][Full Text] [Related]
35. The mechanisms of action of PPARs.
Berger J; Moller DE
Annu Rev Med; 2002; 53():409-35. PubMed ID: 11818483
[TBL] [Abstract][Full Text] [Related]
36. Thiazolidinediones-improving endothelial function and potential long-term benefits on cardiovascular disease in subjects with type 2 diabetes.
Dandona P; Ghanim H; Chaudhuri A; Mohanty P
J Diabetes Complications; 2008; 22(1):62-75. PubMed ID: 18191079
[TBL] [Abstract][Full Text] [Related]
37. Decoding transcriptional programs regulated by PPARs and LXRs in the macrophage: effects on lipid homeostasis, inflammation, and atherosclerosis.
Ricote M; Valledor AF; Glass CK
Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):230-9. PubMed ID: 14592855
[TBL] [Abstract][Full Text] [Related]
38. The vascular biology of atherosclerosis.
Plutzky J
Am J Med; 2003 Dec; 115 Suppl 8A():55S-61S. PubMed ID: 14678867
[TBL] [Abstract][Full Text] [Related]
39. [PPARgamma and atheroma].
Staels B
Ann Endocrinol (Paris); 2002 Apr; 63(2 Pt 2):1S23-6. PubMed ID: 12037504
[TBL] [Abstract][Full Text] [Related]
40. Inflammation in diabetes mellitus: role of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma agonists.
Libby P; Plutzky J
Am J Cardiol; 2007 Feb; 99(4A):27B-40B. PubMed ID: 17307056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
